Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Patient-acceptable symptom state as an outcome measure in the daily care of patients with ankylosing spondylitis.

Rodríguez-Lozano C, Gantes MÁ, González B, Hernández-Beriain JA, Naranjo A, Hernández V, Quevedo-Abeledo JC, Falcón MJ, Machín S, Descalzo MA.

J Rheumatol. 2012 Jul;39(7):1424-32. doi: 10.3899/jrheum.111481. Epub 2012 Jun 1.

PMID:
22660807
2.

Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.

Godfrin-Valnet M, Prati C, Puyraveau M, Toussirot E, Letho-Gyselink H, Wendling D.

Joint Bone Spine. 2013 Jul;80(4):393-8. doi: 10.1016/j.jbspin.2013.01.003. Epub 2013 Mar 1.

PMID:
23453478
3.

Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis.

Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A.

Arthritis Rheum. 2007 Feb 15;57(1):133-9.

4.

Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.

Tubach F, Pham T, Skomsvoll JF, Mikkelsen K, Bjørneboe O, Ravaud P, Dougados M, Kvien TK.

Arthritis Rheum. 2006 Dec 15;55(6):960-3.

5.

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study.

Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, Felson DT, Hajjaj-Hassouni N, Hochberg M, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D, Dougados M.

Arthritis Care Res (Hoboken). 2012 Nov;64(11):1699-707. doi: 10.1002/acr.21747.

6.

Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics.

Maksymowych WP, Gooch K, Dougados M, Wong RL, Chen N, Kupper H, van der Heijde D.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):826-34. doi: 10.1002/acr.20131.

7.

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.

van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R; Assessment of SpondyloArthritis international Society (ASAS).

Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826. Epub 2008 Dec 5.

PMID:
19060001
8.

Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Kvamme MK, Kristiansen IS, Lie E, Kvien TK.

J Rheumatol. 2010 Jan;37(1):26-31. doi: 10.3899/jrheum.090449. Epub 2009 Dec 1.

PMID:
19955045
9.

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.

Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D; Assessment of SpondyloArthritis international Society.

Ann Rheum Dis. 2009 Jan;68(1):18-24. doi: 10.1136/ard.2008.094870. Epub 2008 Jul 14.

PMID:
18625618
10.

The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis.

Kviatkovsky MJ, Ramiro S, Landewé R, Dougados M, Tubach F, Bellamy N, Hochberg M, Ravaud P, Martin-Mola E, Awada H, Bombardier C, Felson D, Hajjaj-Hassouni N, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D.

J Rheumatol. 2016 Sep;43(9):1680-6. doi: 10.3899/jrheum.151244. Epub 2016 Jun 15.

PMID:
27307522
11.

Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial.

Dougados M, Luo MP, Maksymowych WP, Chmiel JJ, Chen N, Wong RL, Davis JC Jr, van der Heijde D; ATLAS STUDY GROUP.

Arthritis Rheum. 2008 Apr 15;59(4):553-60. doi: 10.1002/art.23527.

12.

Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.

Fernández-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estévez E, Mulero J, Muñoz-Fernández S, Zarco P, Carmona L; ESPERANZA Study Group.

Ann Rheum Dis. 2014 Jul;73(7):1350-5. doi: 10.1136/annrheumdis-2012-202976. Epub 2013 May 24.

PMID:
23709245
13.
14.

Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.

Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Kaufmann C, Rødevand E, Mikkelsen K, Kalstad S, Kvien TK.

Rheumatology (Oxford). 2012 Aug;51(8):1479-83. doi: 10.1093/rheumatology/kes057. Epub 2012 Apr 11.

PMID:
22499062
15.

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.

Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Lambert R, Hansen A, Østergaard M.

Ann Rheum Dis. 2011 Aug;70(8):1375-81. doi: 10.1136/ard.2010.138883. Epub 2011 May 8.

PMID:
21551511
16.

[The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].

DU XN, Li Y, Zhang SL, Zhu J, Huang F.

Zhonghua Nei Ke Za Zhi. 2012 Mar;51(3):206-9. Chinese.

PMID:
22781894
17.

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.

Arthritis Rheum. 2005 Feb;52(2):582-91.

18.
19.
20.

Parent and child acceptable symptom state in juvenile idiopathic arthritis.

Filocamo G, Consolaro A, Schiappapietra B, Ruperto N, Pistorio A, Solari N, Pederzoli S, Verazza S, Martini A, Ravelli A.

J Rheumatol. 2012 Apr;39(4):856-63. doi: 10.3899/jrheum.110745. Epub 2012 Feb 1.

PMID:
22298905

Supplemental Content

Support Center